Of Patents And Production: Industry-White House Row Over Vaccine Exports Highlights Policy Divide

BIO chief calls US Defense Production Act ‘misguided’ as India seeks more COVID vaccines; America will donate AstraZeneca vaccine – just as soon as the FDA determines it was adequately manufactured.

INDIA’S COVID OUTBREAK IS BEGINNING TO PLAY AN OUTSIZED ROLE IN THE SHAPE OF THE PANDEMIC.

International biopharma industry leaders have called on the US government to ease its current controls on supplies of raw materials for COVID-19 vaccines in order to help India combat its explosive outbreak.

However, the White House has responded to criticism of the Defense Production Act (DPA) by denying that it is restricting...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet